Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00891696 · ClinicalTrials.gov registry record · Phase 1
Nutritional and Contractile Regulation of Muscle Growth
A Phase 1 study, sponsored by The University of Texas Medical Branch, Galveston.
- Completed
- Registry status
- Phase 1
- Development phase
- 144
- Enrollment target
NCT00891696 is a Phase 1 study that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 144 participants.
The verdict
NCT00891696, a Phase 1 study, has completed, sponsored by The University of Texas Medical Branch, Galveston.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 144 participants
- Enrollment target
Study Summary
Muscle wasting, which involves the loss of muscle tissue, is common in many conditions, such as cancer, AIDS, trauma, kidney failure, bone fracture, and sepsis. It is also prevalent among the elderly and in people who experience periods of physical inactivity and weightlessness. Muscle wasting can lead to overall weakness, immobility, physical dependence, and a greater risk of death when exposed to infection, surgery, or trauma. There is a need to develop scientifically based treatments that prevent muscle wasting. As one step towards such a goal, this study will examine the physiological and cellular mechanisms that regulate skeletal muscle growth.
Interventions
- DRUG Rapamycin
- OTHER Amino acid supplementation
- OTHER Low-intensity resistance exercise
- DRUG Sodium nitroprusside
- DEVICE Blood flow restriction cuff
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2009-04 |
| Est. Completion | 2015-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00891696
The ClinicalTrials.gov registry entry for NCT00891696 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Rapamycin is the first listed.
NCT00891696 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00891696 about?
NCT00891696 is a clinical study titled "Nutritional and Contractile Regulation of Muscle Growth". Muscle wasting, which involves the loss of muscle tissue, is common in many conditions, such as cancer, AIDS, trauma, kidney failure, bone fracture, and sepsis. It is also prevalent among the elderly and in people who experience periods of physical inactivity and weightlessness. Muscle wasting can l...
What is the current status of trial NCT00891696?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 144 participants. The study started on 2009-04. Estimated completion is 2015-03.
What interventions are being tested in trial NCT00891696?
The interventions under investigation include: Rapamycin (DRUG), Amino acid supplementation (OTHER), Low-intensity resistance exercise (OTHER), Sodium nitroprusside (DRUG), Blood flow restriction cuff (DEVICE).
Who is sponsoring clinical trial NCT00891696?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.